Gip

2 articles

A scientist in a futuristic lab examining a holographic display of a triple hormone receptor drug, representing Pfizer's new obesity treatment.

Cosmos & Physics

Pfizer advances monthly obesity drug targeting triple hormone receptors

Pfizer is advancing a monthly weight-loss injection, danuglipron, having announced positive early-stage data.

Dr. Evelyn Reed·June 7, 2026

A glowing, complex quintuple agonist molecule in a futuristic lab, representing a breakthrough in obesity and diabetes treatment.

Cosmos & Physics

New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice

In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP

Dr. Evelyn Reed·May 18, 2026